Inhibrx, Inc.

Delisted

CIK 1739614fmd_0M7Q5WJ1Q20KMTN8FEE65AST3NManufacturing · Biological Products, (No Diagnostic Substances)Template: Standard

Coverage: Jan 01, 2019 to Mar 31, 2024, 21 periods

AI-written

A model wrote this from the company's own SEC filings and our standardized facts. It is not reported fact, not an analyst's estimate, not a rating and not investment advice. Every claim shows what it rests on.